eflornithine has been researched along with Hepatitis C in 1 studies
Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.
Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lesnova, EI | 1 |
| Masalova, OV | 1 |
| Permyakova, KY | 1 |
| Kozlov, VV | 1 |
| Nikolaeva, TN | 1 |
| Pronin, AV | 1 |
| Valuev-Elliston, VT | 1 |
| Ivanov, AV | 1 |
| Kushch, AA | 1 |
1 other study available for eflornithine and Hepatitis C
| Article | Year |
|---|---|
Difluoromethylornithine (DFMO), an Inhibitor of Polyamine Biosynthesis, and Antioxidant
Topics: Acetylcysteine; Adjuvants, Immunologic; Animals; Cell Proliferation; Cells, Cultured; Eflornithine; | 2021 |